Effects of In-office Dispensing by Single-specialty Urology Practices on Management of Advanced Prostate Cancer
- 1 May 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Urology Practice
- Vol. 10 (3) , 230-235
Abstract
Objective:To examine changes in the volume of patients with advanced prostate cancer and prescriptions for abiraterone and enzalutamide among urology practices with and without in-office di...Keywords
This publication has 16 references indexed in Scilit:
- Temporal and geographic variation in the systemic treatment of advanced prostate cancerBMC Cancer, 2018
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone TherapyNew England Journal of Medicine, 2017
- In-office dispensing of oral oncolytics: a continuity of care and cost mitigation model for cancer patients.2016
- Mind the Gap: Why Closing the Doughnut Hole Is Insufficient for Increasing Medicare Beneficiary Access to Oral ChemotherapyJournal of Clinical Oncology, 2016
- New Treatment Options in Castration-Resistant Prostate CancerJournal of the National Comprehensive Cancer Network, 2015
- Enzalutamide in Metastatic Prostate Cancer before ChemotherapyNew England Journal of Medicine, 2014
- Abiraterone in Metastatic Prostate Cancer without Previous ChemotherapyNew England Journal of Medicine, 2013
- Increased Survival with Enzalutamide in Prostate Cancer after ChemotherapyNew England Journal of Medicine, 2012
- Prostate Cancer, Version 3.2012 Featured Updates to the NCCN GuidelinesJournal of the National Comprehensive Cancer Network, 2012
- Abiraterone and Increased Survival in Metastatic Prostate CancerNew England Journal of Medicine, 2011